Cargando…

Cytokines as Mediators of Chemotherapy-Associated Cognitive Changes: Current Evidence, Limitations and Directions for Future Research

OBJECTIVES: While various clinical and pharmacological determinants for chemotherapy-associated cognitive impairment have been identified, conflicting evidence suggests that cytokines might play an intermediary role. The objective of this systematic review was to evaluate the current evidence pertai...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Yin Ting, Lim, Si Rong, Ho, Han Kiat, Chan, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855252/
https://www.ncbi.nlm.nih.gov/pubmed/24339912
http://dx.doi.org/10.1371/journal.pone.0081234
_version_ 1782294905963413504
author Cheung, Yin Ting
Lim, Si Rong
Ho, Han Kiat
Chan, Alexandre
author_facet Cheung, Yin Ting
Lim, Si Rong
Ho, Han Kiat
Chan, Alexandre
author_sort Cheung, Yin Ting
collection PubMed
description OBJECTIVES: While various clinical and pharmacological determinants for chemotherapy-associated cognitive impairment have been identified, conflicting evidence suggests that cytokines might play an intermediary role. The objective of this systematic review was to evaluate the current evidence pertaining to the associations among chemotherapy, cytokines induction and cognitive impairment in cancer patients. METHODS: A literature search with PubMed and SciVerse Scopus was conducted in March 2013 to gather relevant articles and abstracts that fulfilled the inclusion and exclusion criteria. This review included studies that had performed objective and/or subjective cognitive assessments and cytokine measurements on defined populations of cancer patients who received chemotherapy. RESULTS: High methodological heterogeneity existed among the selected studies which differed in cancer populations, subject characteristics, cognitive endpoints, types of cytokines tested and their measurement methods. Weak to moderate correlations were observed between IL-1β, IL-6, TNF-α levels, and different degrees of cognitive impairment. Different types of chemotherapy treatments might lead to varying presentations and severities of cytokine-induced cognitive impairment. Notably, the time concordance between the onset of cytokine induction and occurrence of cognitive impairment was not well elucidated. A number of confounding factors was identified to interfere with the expression levels of cytokines; these confounders included subjects' cancer types, ages, genders, genetics and psychosocial characteristics such as anxiety, depression and fatigue. CONCLUSION: Although existing studies observed cognitive impairment and cytokine dysregulation in patients who receive chemotherapy, our results suggest that the intermediary role of cytokines in post-chemotherapy cognitive impairment is still controversial and requires further evaluation. A list of methodological recommendations is proposed to harmonize future studies of this subject matter.
format Online
Article
Text
id pubmed-3855252
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38552522013-12-11 Cytokines as Mediators of Chemotherapy-Associated Cognitive Changes: Current Evidence, Limitations and Directions for Future Research Cheung, Yin Ting Lim, Si Rong Ho, Han Kiat Chan, Alexandre PLoS One Research Article OBJECTIVES: While various clinical and pharmacological determinants for chemotherapy-associated cognitive impairment have been identified, conflicting evidence suggests that cytokines might play an intermediary role. The objective of this systematic review was to evaluate the current evidence pertaining to the associations among chemotherapy, cytokines induction and cognitive impairment in cancer patients. METHODS: A literature search with PubMed and SciVerse Scopus was conducted in March 2013 to gather relevant articles and abstracts that fulfilled the inclusion and exclusion criteria. This review included studies that had performed objective and/or subjective cognitive assessments and cytokine measurements on defined populations of cancer patients who received chemotherapy. RESULTS: High methodological heterogeneity existed among the selected studies which differed in cancer populations, subject characteristics, cognitive endpoints, types of cytokines tested and their measurement methods. Weak to moderate correlations were observed between IL-1β, IL-6, TNF-α levels, and different degrees of cognitive impairment. Different types of chemotherapy treatments might lead to varying presentations and severities of cytokine-induced cognitive impairment. Notably, the time concordance between the onset of cytokine induction and occurrence of cognitive impairment was not well elucidated. A number of confounding factors was identified to interfere with the expression levels of cytokines; these confounders included subjects' cancer types, ages, genders, genetics and psychosocial characteristics such as anxiety, depression and fatigue. CONCLUSION: Although existing studies observed cognitive impairment and cytokine dysregulation in patients who receive chemotherapy, our results suggest that the intermediary role of cytokines in post-chemotherapy cognitive impairment is still controversial and requires further evaluation. A list of methodological recommendations is proposed to harmonize future studies of this subject matter. Public Library of Science 2013-12-05 /pmc/articles/PMC3855252/ /pubmed/24339912 http://dx.doi.org/10.1371/journal.pone.0081234 Text en © 2013 Cheung et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Cheung, Yin Ting
Lim, Si Rong
Ho, Han Kiat
Chan, Alexandre
Cytokines as Mediators of Chemotherapy-Associated Cognitive Changes: Current Evidence, Limitations and Directions for Future Research
title Cytokines as Mediators of Chemotherapy-Associated Cognitive Changes: Current Evidence, Limitations and Directions for Future Research
title_full Cytokines as Mediators of Chemotherapy-Associated Cognitive Changes: Current Evidence, Limitations and Directions for Future Research
title_fullStr Cytokines as Mediators of Chemotherapy-Associated Cognitive Changes: Current Evidence, Limitations and Directions for Future Research
title_full_unstemmed Cytokines as Mediators of Chemotherapy-Associated Cognitive Changes: Current Evidence, Limitations and Directions for Future Research
title_short Cytokines as Mediators of Chemotherapy-Associated Cognitive Changes: Current Evidence, Limitations and Directions for Future Research
title_sort cytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future research
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855252/
https://www.ncbi.nlm.nih.gov/pubmed/24339912
http://dx.doi.org/10.1371/journal.pone.0081234
work_keys_str_mv AT cheungyinting cytokinesasmediatorsofchemotherapyassociatedcognitivechangescurrentevidencelimitationsanddirectionsforfutureresearch
AT limsirong cytokinesasmediatorsofchemotherapyassociatedcognitivechangescurrentevidencelimitationsanddirectionsforfutureresearch
AT hohankiat cytokinesasmediatorsofchemotherapyassociatedcognitivechangescurrentevidencelimitationsanddirectionsforfutureresearch
AT chanalexandre cytokinesasmediatorsofchemotherapyassociatedcognitivechangescurrentevidencelimitationsanddirectionsforfutureresearch